Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AstraZeneca to sell Synagis US rights to Sobi for $1.5bn
Image: AstraZeneca to divest US rights of Synagis to Sobi for $1.5bn. Photo: courtesy of Astrazeneca.
Image: AstraZeneca to divest US rights of Synagis to Sobi for $1.5bn. Photo: courtesy of Astrazeneca.